Atlas Trials

The Role of Endothelin 1 as a Marker of Renal Impairment in Sickle Cell Disease

Clinical trial NCT06158945 · UNKNOWN

Trial details

NCT number
NCT06158945
Sponsor
Sohag University
Status
UNKNOWN
Study type
OBSERVATIONAL
Sickle Cell Disease
Start date
2023-10-24
Primary completion
2024-10-23
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.